Canada | Imports and Exports | World | Medicaments (excluding goods of heading 3002, 3005 or 3006) consisting of two or more constituents | Value (US$) and Value Growth, YoY (%) | 2012 - 2023
The value of exports of commodity group 3003 "Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale" from Canada totalled $ 137 million in 2023. Sales of commodity group 3003 from Canada went up by 15.1% compared to 2022: exports of commodity group 3003 "Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale" went up by $ 18.1 million (cumulative exports of commodity group 3003 from Canada amounted $119 million in 2022)
Exports of commodity group 3003 "Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale" amounted to 0.024% of total exports from Canada (cumulative merchandise exports from Canada totalled $ 566 billion in 2023). The share of commodity group 3003 in total exports from Canada increased by 0.004 p.p. compared to 2022 (it was 0.02% in 2022 and cumulative exports from Canada were equal to $ 596 billion).
Exports of commodity group 3003 amounted to 1.43% of total sales of group "" from Canada in 2023 (the value of exports of commodity group from Canada amounted to $9.58 billion in 2023). The share of exports of commodity group 3003 in sales of commodity group from Canada increased by 0.322 p.p. compared to 2022 (it was 1.11% in 2022, and exports of commodity group from Canada were $10.7 billion).
Where does Canada export Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale?
Top export destinations of "Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale" from Canada in 2023:
- USA with a share of 25% (35 million US$)
- Belgium with a share of 22% (31 million US$)
- Ireland with a share of 11.7% (16.1 million US$)
- India with a share of 9.67% (13.3 million US$)
- Netherlands with a share of 4.61% (6.36 million US$)
- South Africa with a share of 3.3% (4.56 million US$)
- Korea with a share of 3.18% (4.39 million US$)
- Turkey with a share of 3.06% (4.22 million US$)
- Brazil with a share of 2.9% (4 million US$)
- Pakistan with a share of 2.44% (3.36 million US$)
Exports structure of 3003 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale - from Canada in 2023 represented by the following main commodity groups:
- 69% (95 million US$): 300390 - Medicaments (excl. of 30.02/30.05/30.06) consisting of mixed/unmixed products for therapeutic/propnylactic uses, not put up in measured doses/forms/packagings for retail sale [see complete text #27]
- 17.5% (24 million US$): 300320 - Medicaments consisting of 2/more constituents, cont. other antibiotics (excl. of 3003.10), not put up in measured doses/forms/packagings for retail sale
- 12.1% (16.7 million US$): 300339 - Medicaments cont. hormones/other products of 29.37 but not cont. antibiotics (excl. meds. cont. insulin), not put up in measured doses/forms/packagings for retail sale
- 0.033% (46 thousand US$): 300310 - Medicaments cont. penicillins/derivatives thereof with a penicillanic acid structure/streptomycins/their derivatives, not put up in measured doses/forms/packagings for retail sale
The value of imports of commodity group 3003 "Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale" to Canada totalled $ 1.98 billion in 2023. Sales of commodity group 3003 to Canada went up by 83% compared to 2022: imports of commodity group 3003 "Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale" went up by $ 902 million (the value of imports of commodity group 3003 to Canada was equal to $1.08 billion in 2022)
Imports of commodity group 3003 "Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale" accounted for 0.355% of total import flow to Canada (in 2023, total imports to Canada amounted to $ 558 billion). The share of commodity group 3003 in total imports to Canada increased by 0.165 p.p. compared to 2022 (it was 0.189% in 2022 and cumulative imports to Canada were equal to $ 569 billion).
Imports of commodity group 3003 reached 10.4% of total imports of group "" to Canada in 2023 (imports of commodity group to Canada totalled $18.8 billion in 2023). The share of purchases of commodity group 3003 in total imports of commodity group to Canada increased by 5.1 p.p. compared to 2022 (it was 5.39% in 2022, and imports of commodity group to Canada accounted for $20 billion).
Where does Canada import Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale from?
Top trading partners (import of "Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale") of Canada in 2023:
- Portugal with a share of 94% (1.88 billion US$)
- USA with a share of 1.88% (37 million US$)
- Ireland - 11.8 million US$
- United Kingdom - 11.6 million US$
- China - 10.5 million US$
- Spain - 8.79 million US$
- India - 5.94 million US$
- Turkey - 4.5 million US$
- Sweden - 2.25 million US$
- Italy - 1.88 million US$
Imports structure of 3003 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale - to Canada in 2023 represented by the following main commodity groups:
- 98% (1.95 billion US$): 300390 - Medicaments (excl. of 30.02/30.05/30.06) consisting of mixed/unmixed products for therapeutic/propnylactic uses, not put up in measured doses/forms/packagings for retail sale [see complete text #27]
- 0.581% (11.5 million US$): 300339 - Medicaments cont. hormones/other products of 29.37 but not cont. antibiotics (excl. meds. cont. insulin), not put up in measured doses/forms/packagings for retail sale
- 0.557% (11 million US$): 300320 - Medicaments consisting of 2/more constituents, cont. other antibiotics (excl. of 3003.10), not put up in measured doses/forms/packagings for retail sale
- 0.051% (1.01 million US$): 300310 - Medicaments cont. penicillins/derivatives thereof with a penicillanic acid structure/streptomycins/their derivatives, not put up in measured doses/forms/packagings for retail sale
- 0.003% (64 thousand US$): 300331 - Medicaments cont. insulin, not put up in measured doses/forms/packagings for retail sale
